|
ZNF621 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.823400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.437500E-02 |
| Normal-vs-Stage2 |
2.115800E-01 |
| Normal-vs-Stage3 |
4.579800E-04 |
| Normal-vs-Stage4 |
6.934500E-02 |
| Stage1-vs-Stage2 |
9.857400E-01 |
| Stage1-vs-Stage3 |
2.073700E-02 |
| Stage1-vs-Stage4 |
6.208400E-01 |
| Stage2-vs-Stage3 |
1.223220E-01 |
| Stage2-vs-Stage4 |
7.352000E-01 |
| Stage3-vs-Stage4 |
2.335400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.080500E-03 |
| Normal-vs-AfricanAmerican |
5.040800E-01 |
| Normal-vs-Asian |
2.527600E-01 |
| Caucasian-vs-AfricanAmerican |
1.631820E-01 |
| Caucasian-vs-Asian |
8.170300E-02 |
| AfricanAmerican-vs-Asian |
2.230400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.884200E-03 |
| Normal-vs-Female |
6.897900E-02 |
| Male-vs-Female |
4.203800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.762600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.550500E-02 |
| Normal-vs-Age(61-80Yrs) |
6.119300E-03 |
| Normal-vs-Age(81-100Yrs) |
7.757400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.996000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.101800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.601800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.235600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.076150E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.309600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.387400E-01 |
| Normal-vs-Grade 2 |
8.171600E-02 |
| Normal-vs-Grade 3 |
1.078080E-02 |
| Normal-vs-Grade 4 |
5.635700E-03 |
| Grade 1-vs-Grade 2 |
1.941790E-01 |
| Grade 1-vs-Grade 3 |
5.576500E-02 |
| Grade 1-vs-Grade 4 |
3.776300E-02 |
| Grade 2-vs-Grade 3 |
2.357200E-01 |
| Grade 2-vs-Grade 4 |
1.480970E-01 |
| Grade 3-vs-Grade 4 |
4.948800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.309800E-02 |
| Normal-vs-ccB subtype |
7.025600E-02 |
| ccA subtype-vs-ccB subtype |
7.074400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.209700E-02 |
| Normal-vs-N1 |
4.313000E-01 |
| N0-vs-N1 |
8.084400E-01 |
|
|
